Clinical Trials Browser

Interventional × Has results × Psoriasis × Clear all

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

NCT03721172 2024-05-29

ADVANCE

Phase 3 Completed

595 enrolled 19 charts

Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis

NCT00585650 2023-08-18

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Phase 1/2 Completed

20 enrolled 5 charts

Psoriasis

NCT01490632 2019-09-27

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Phase 2 Completed

271 enrolled 32 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, Plaque, Amyloid

NCT00924950 2019-04-18

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

Phase 4 Terminated

35 enrolled 3 charts

Sarcoma

Psoriasis, Rhabdomyosarcoma, Alveolar

NCT01815424 2019-04-16

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Phase 3 Completed

266 enrolled 58 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01961609 2019-03-18

SIGNATURE

Phase 3 Completed

235 enrolled 23 charts

Psoriasis

NCT01186744 2018-12-26

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

666 enrolled 110 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

1,101 enrolled 46 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

NCT02196701 2018-03-19

CLEAR

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

NCT01053819 2018-02-23

Can We Miss Pigmented Lesions in Psoriasis Patients?

Phase 4 Completed

6 enrolled 3 charts

Dermatologic

Melanoma, Psoriasis

NCT00932113 2017-08-31

MOA

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

NCT01163253 2017-06-26

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Terminated

2,867 enrolled 77 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis

NCT01313221 2017-03-15

REFINE

Phase 3 Completed

310 enrolled 32 charts

Lymphoid

Lymphoma, Follicular, Psoriasis

NCT01831466 2015-11-25

Tofacitinib Ointment For Chronic Plaque Psoriasis

Phase 2 Completed

476 enrolled 33 charts

Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis, Skin Diseases

NCT01519089 2015-08-13

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Phase 3 Completed

95 enrolled 37 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Arthritis, Psoriatic

NCT01276639 2014-09-19

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

901 enrolled 56 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

Clinical Trials

VITAL

ADVANCE

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

SIGNATURE

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

CLEAR

Can We Miss Pigmented Lesions in Psoriasis Patients?

MOA

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

REFINE

Tofacitinib Ointment For Chronic Plaque Psoriasis

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis